Cefepime is a fourth-generation cephalosporin antibiotic with broad activity, including against hospital-acquired and resistant bacterial strains. Tazobactam inhibits β-lactamase enzymes, enhancing the effect of cefepime.
Recommended for:
Treatment of severe infections caused by susceptible microorganisms, including pneumonia, urinary tract infections, skin infections, intra-abdominal infections, and sepsis.
Administered intravenously or intramuscularly after reconstitution of the powder. Dosage and frequency are determined by the physician based on infection severity and renal function.
Contraindications
Side effects
